Iatrogenic Kaposi sarcoma during tumor necrosis factor alpha inhibitors
Ital J Dermatol Venerol
.
2021 Feb;156(1):113-114.
doi: 10.23736/S2784-8671.20.06595-5.
Epub 2020 Jun 15.
Authors
Alba Guglielmo
1
,
Clara Bertuzzi
2
,
Eleonora Scaioli
3
,
Andrea Belluzzi
3
,
Elena Sabattini
2
,
Annalisa Patrizi
4
,
Alessandro Pileri
4
Affiliations
1
Unit of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy - albaguglielmo@gmail.com.
2
Unit of Hematopathology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
3
Department of Medical and Surgical Sciences DIMEC, S. Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.
4
Unit of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
PMID:
32545944
DOI:
10.23736/S2784-8671.20.06595-5
No abstract available
MeSH terms
Herpesvirus 8, Human*
Humans
Iatrogenic Disease
Sarcoma, Kaposi* / chemically induced
Skin Neoplasms*
Tumor Necrosis Factor-alpha
Substances
Tumor Necrosis Factor-alpha